Skip to content

A randomized controlled trial of repetitive transcranial magnetic stim-ulation combined brain computer interface therapy for depression pa-tients: Effects on cognitive performance and neurotrophic growth factor

A randomized controlled trial of repetitive transcranial magnetic stim-ulation combined brain computer interface therapy for depression pa-tients: Effects on cognitive performance and neurotrophic growth factor

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085307
Enrollment
Unknown
Registered
2024-06-05
Start date
2024-06-07
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

rTMS combined BCI training group:rTMS combined BCI pedaling training
sham rTMS combined BCI training group:sham rTMS combined BCI pedaling training

Sponsors

Department of rebabilitation medicine of Air Force Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) 18-55 years old, Han Chines with injury but not influence lower limb motor function; (2) Accord with the diagnostic criteria of unipolar, no-psychotic major depressive disorder (MDD) according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR); (3) A sum of score of the 17-item Hamilton Depression Rating Scale (HDRS-17) was = 17. (4) Patients without sever orthopedic issue; (5) Without participated in aerobic training or any other exercise programs in the past 3 month;

Exclusion criteria

Exclusion criteria: (1) History of serious substance abuse, alcohol dependence or smoking. (2) History of musculoskeletal dysfunction, mental or neurological disorders; (3) A current head trauma or history of organic brain disorders; (4) Severe tenden-cy of suicide as shown by a score of 3 or 4 on the suicide item of HDRS-17; (5) Previous or current psychotropic treatment and psychotherapy; (6) Implanted device or metal in the brain or heart; (7) Previous or current receive other neurostimulation (including tDCS, iTBS and tACS);

Design outcomes

Primary

MeasureTime frame
cognitive function;neurotrophic performance;

Secondary

MeasureTime frame
Hamilton Depression Rating Scale-17 items;the Patient Health Questionnaire-9 items;the Generalized Anxiety Disorder scale-7 items;the Pittsburgh Sleep Quality Index;

Countries

China

Contacts

Public ContactYe Chaoqun

Air Force Medical Center of Chinese PLA

yecq2023@foxmail.com+86 10 6610 6225

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026